U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07879612) titled 'Semaglutide for the Treatment of Cannabis Use Disorder' on Oct. 06.
Brief Summary: The goal of this pilot study is to learn about the effects of semaglutide on brain reactivity to cannabis-related cues in adults with cannabis use disorder. The main questions it aims to answer are:
1. Does semaglutide effect reactivity to cannabis-related cues?
2. Does semaglutide safely reduce the frequency of cannabis use?
Participants will complete five in-person study visits over 9 weeks, which will include interviews, questionnaires, and collection of biological samples for laboratory testing. fMRI scans will be completed at two visits. All p...